1. Home
  2. EXPO vs AMRX Comparison

EXPO vs AMRX Comparison

Compare EXPO & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$65.36

Market Cap

3.4B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.48

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
AMRX
Founded
1967
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
EXPO
AMRX
Price
$65.36
$12.48
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$88.00
$15.60
AVG Volume (30 Days)
412.9K
1.3M
Earning Date
04-30-2026
05-01-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
157.89
EPS
2.07
0.22
Revenue
$582,014,000.00
N/A
Revenue This Year
$12.75
$4.48
Revenue Next Year
$8.50
$7.13
P/E Ratio
$31.95
$57.32
Revenue Growth
4.21
N/A
52 Week Low
$63.25
$7.02
52 Week High
$81.95
$15.42

Technical Indicators

Market Signals
Indicator
EXPO
AMRX
Relative Strength Index (RSI) 41.10 45.67
Support Level $64.33 $12.50
Resistance Level $73.62 $12.85
Average True Range (ATR) 2.02 0.49
MACD 0.09 0.01
Stochastic Oscillator 24.95 28.01

Price Performance

Historical Comparison
EXPO
AMRX

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: